The Centers for Disease Control and Prevention has published the Recommended Childhood and Adolescent Immunization Schedule for 2005. It is available from the CDC at http://www.cdc.gov/.
FDA approves 20-valent pneumococcal conjugate vaccine for infants 6 weeks and older
April 28th 2023According to Pfizer, the company’s pneumococcal conjugate vaccine Prevnar 20 has been approved by the FDA to treat infants and children aged 6 weeks to 17 years for the prevention of invasive pneumococcal disease (IPD).
2 Clarke Drive
Cranbury, NJ 08512